Evidence map›Paper›PMID 32426354›Full record

ReviewFrontiers in cell and developmental biology2020

Phosphorylation-Dependent Pin1 Isomerization of ATR: Its Role in Regulating ATR's Anti-apoptotic Function at Mitochondria, and the Implications in Cancer.

Yetunde Makinwa, Phillip R Musich, Yue Zou

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Pin1 and Alzheimer's disease.Translational research : the journal of laboratory and clinical medicine · 2023
    Review
  6. Article
  7. Article
  8. The regulatory role of Pin1 in neuronal death.Neural regeneration research · 2023
    Review
  9. SelectiveAngewandte Chemie (International ed. in English) · 2022
    Article
  10. Article
  11. A bibliometric analysis of PIN1 and cell death.Frontiers in cell and developmental biology · 2022
    Article
  12. Juglone and KPT6566 Suppress the Tumorigenic Potential of CD44Frontiers in cell and developmental biology · 2022
    Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yetunde MakinwaDepartment of Cancer Biology, University of Toledo College of Medicine, Toledo, OH, United States.
Phillip R MusichDepartment of Biomedical Sciences, JH Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
Yue ZouDepartment of Cancer Biology, University of Toledo College of Medicine, Toledo, OH, United States.
East Tennessee State University · USUniversity of Toledo · US

Funding

RECOGNITION AND REPAIR OF UV DAMAGE TO HUMAN DNAR01CA086927 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ZOU, YUE · 2000 to 2011
$2.2M
ATR Isomerization in Cellular Responses to UV Damage of DNAR01CA219342 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI ZOU, YUE · 2017 to 2022
$1.8M
Antiapoptotic Role of Ataxia Telangiectasia and Rad3-RelatedR15GM112168 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI ZOU, YUE · 2014 to 2016
$422k
NCI NIH HHS R01 CA086927NCI NIH HHS R01 CA219342NIGMS NIH HHS R15 GM112168
6 · The paper itself

Abstract

Peptidyl-prolyl isomerization is an important post-translational modification of protein because proline is the only amino acid that can stably exist as

Indexed as

antiapoptotic ATRapoptosiscancercis and transcytoplasmic ATRPin1prolyl isomerization

Identifiers

PMID32426354
PMCPMC7203486
OpenAlexW3021536036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.